Host: Matt Birnholz, MD <br>


  <p>To help keep the risk of COVID-19 at bay, the National Psoriasis Foundation’s COVID-19 Task Force set out to determine how we can safely continue treating our patients with psoriatic arthritis. Tune in as Dr. Matt Birnholz discusses the strategies identified by the COVID-19 Task Force.</p>

Host: Matt Birnholz, MD To help keep the risk of COVID-19 at bay, the National Psoriasis Foundation’s COVID-19 Task Force set out to determine how we can safely continue treating our patients with psoriatic arthritis. Tune in as Dr. Matt Birnholz discusses the strategies identified by the COVID-19 Task Force.

Treating PsA in a Pandemic: Recommendations from the COVID-19 Task Force

Occurring in 20-30% of patients with psoriasis, PsA causes painful joint stiffness and swelling, often becoming worse over time. Currently, there is no known cure for PsA.
Beyond Skin Deep: Impacts of Psoriatic Arthritis takes an in-depth look at PsA, exploring the care continuum from disease recognition to diagnosis to treatment.
This non-certified educational series is sponsored by Lilly. Content for this series is produced and controlled by ReachMD. This series is intended for healthcare professionals only. 
 Sponsored by

Medicine

Occurring in 20-30% of patients with psoriasis, PsA causes painful joint stiffness and swelling, often becoming worse over time. Currently, there is no known cure for PsA. Beyond Skin Deep: Impacts of Psoriatic Arthritis takes an in-depth look at PsA, exploring the care continuum from disease recognition to diagnosis to treatment. This non-certified educational series is sponsored by Lilly. Content for this series is produced and controlled by ReachMD. This series is intended for healthcare professionals only. Sponsored by

Occurring in 20-30% of patients with psoriasis, PsA causes painful joint stiffness and swelling, often becoming worse over time. Currently, there is no known cure for PsA.
Beyond Skin Deep: Impacts of Psoriatic Arthritis takes an in-depth look at PsA, exploring the care continuum from disease recognition to diagnosis to treatment.
This non-certified educational series is sponsored by Lilly. Content for this series is produced and controlled by ReachMD. This series is intended for healthcare professionals only. 
&nbsp;Sponsored by

Share Treating PsA in a Pandemic: Recommendations from the COVID-19 Task Force

Sign up to save your podcasts

Treating PsA in a Pandemic: Recommendations from the COVID-19 Task Force

Treating PsA in a Pandemic: Recommendations from the COVID-19 Task Force